{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Lidocaine , given in a 300 mg dose intramuscularly followed by 100 mg intravenously , did not prevent sustained ventricular tachycardia , although there was a significant reduction in the number of patients with warning arrhythmias between 15 and 45 minutes after the administration of lidocaine ( p less than 0 . 05 ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| sustained ventricular tachycardia |\n| warning arrhythmias |\n\nIn the given paragraph, the two disease entities are \"sustained ventricular tachycardia\" and \"warning arrhythmias\"."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| sustained ventricular tachycardia |\n| warning arrhythmias |\n\nIn this paragraph, the terms \"sustained ventricular tachycardia\" and \"warning arrhythmias\" are the only entities that clearly refer to diseases. The other terms mentioned in the paragraph, such as \"lidocaine\" and \"intramuscularly,\" are medical procedures or treatments, not diseases."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Lidocaine , given in a 300 mg dose intramuscularly followed by 100 mg intravenously , did not prevent sustained ventricular tachycardia , although there was a significant reduction in the number of patients with warning arrhythmias between 15 and 45 minutes after the administration of lidocaine ( p less than 0 . 05 ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Lidocaine |\n| 300 mg dose intramuscularly followed by 100 mg intravenously |\n\nExplanation:\n\nThe chemical entities in the paragraph are \"Lidocaine\", and \"300 mg dose intramuscularly followed by 100 mg intravenously\". I have included the dosage information for the latter as it is relevant to the context and provides important information about the administration of the drug."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Lidocaine |\n\nExplanation:\n\nThe only clear chemical entity in the paragraph is \"Lidocaine\". The phrase \"300 mg dose intramuscularly followed by 100 mg intravenously\" refers to a specific dosage and method of administration of the drug, but it does not in itself refer to a chemical entity."}
  ]
}